Insider · CIK 0001257825
John J Monahan
Files at TOVX (Theriva Biologics, Inc.). First filing -, latest -.
In brief
John J Monahan files SEC Form 4 as director at TOVX (Theriva Biologics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John J Monahan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | TOVX Theriva Biologics, Inc. | AGrant or award Stock Options (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 6, 2026 |
| Apr 29, 2025 | TOVX Theriva Biologics, Inc. | AGrant or award Stock Options (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | May 1, 2025 |
Questions about John J Monahan
Answered from the filings on this page, as of the latest one.
Is John J Monahan buying or selling?
John J Monahan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John J Monahan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John J Monahan has 0.
Where does John J Monahan file Form 4?
John J Monahan has filed Form 4 at TOVX (Theriva Biologics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.